InsiderTrades

Form 4 for UTHR UNITED THERAPEUTICS Corp

Accepted 2025-11-18 00:00:00 ET · period of report 2025-11-17 · accession 0001673232-25-000012 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMTI 2025-11-18 2025-11-17 UTHR BENKOWITZ MICHAEL Pres AND COO M - OptEx $139.13 +22.5K 7,875 New +$3.13M
DMTI 2025-11-18 2025-11-17 UTHR BENKOWITZ MICHAEL Pres AND COO S - Sale+OE $470.43 -22.5K 0 -100% -$10.58M
DMTI 2025-11-18 2025-11-17 UTHR BENKOWITZ MICHAEL Pres AND COO M - OptEx $0.00 -22.5K 37.7K -37% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-11-17 M A 14,625 $135.42 14,625 I by Trust — — (F2) Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.
2 Common Common Stock 2025-11-17 S D 14,625 $470.43 0 I by Trust — — (F2) Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.
3 Common Common Stock 2025-11-17 M A 2,625 $146.03 2,625 I by Trust — — (F3) Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.
4 Common Common Stock 2025-11-17 M A 5,250 $146.03 7,875 I by Trust — — (F3) Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.
5 Common Common Stock 2025-11-17 S D 7,875 $470.43 0 I by Trust — — (F3) Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.
6 Derivative Stock Options 2025-11-17 M D 14,625 $0.00 12,000 I by Trust $135.42 · 2023-03-15 to 2026-03-15 14,625 Common Stock (F2) Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.
7 Derivative Stock Options 2025-11-17 M D 2,625 $0.00 0 I by Trust $146.03 · 2023-03-15 to 2026-03-15 2,625 Common Stock (F3) Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.
8 Derivative Stock Options 2025-11-17 M D 5,250 $0.00 37,690 I by Trust $146.03 · 2023-03-15 to 2026-03-15 5,250 Common Stock (F3) Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.